LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for treating ...
This is read by an automated voice. Please report any issues or inconsistencies here. California to begin universal screening of kindergarten through second-grade students for reading difficulties, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback